Aurobindo Pharma arm Eugia’s manufacturing unit is classified by the USFDA as official action indicated
Aurobindo Pharma: The United States Food and Drug Administration (US FDA) recently inspected Unit III, A formula production facility of Aurobindo Pharma’s entirely owned subsidiary, Eugia Pharma Specialities. The inspection took place from January 22 to February 2, 2024, at the facility located in Sangareddy District, Telangana. Following the inspection, the US FDA has classified…
